Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
17-OHPC in Pregnancy: IM vs SC Routes
- Conditions
- Preterm Birth
- Interventions
- First Posted Date
- 2019-12-03
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Steve N. Caritis, MD
- Target Recruit Count
- 24
- Registration Number
- NCT04183452
- Locations
- 🇺🇸
Christiana Care, Newark, Delaware, United States
🇺🇸Duke University Medical Center, Durham, North Carolina, United States
🇺🇸Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States
Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy
- Conditions
- PregnancyOpiate Addiction
- Interventions
- Drug: Frequency GroupDrug: Magnitude Group
- First Posted Date
- 2019-02-05
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Steve N. Caritis, MD
- Target Recruit Count
- 13
- Registration Number
- NCT03831113
- Locations
- 🇺🇸
Univerity of Pittsburgh Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸High Risk Obstetrical Consultants, Knoxville, Tennessee, United States
Relationship Between Plasma Concentration of Hydroxyprogesterone Caproate (17-OHPC) and Preterm Birth
- Conditions
- Preterm Birth
- Interventions
- Drug: Safety study of 500 mg dose.
- First Posted Date
- 2017-09-26
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Steve N. Caritis, MD
- Target Recruit Count
- 159
- Registration Number
- NCT03292731
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸University of Pittsburgh-Magee Womens Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸University of Texas Medical Branch, Galveston, Texas, United States